Evonik | Digital Content

Evonik completes sale of superabsorbents business to ICIG

02 Sep 2024

// REUTERS

Evonik expands its formulation capabilities for lipid nanoparticles

16 Aug 2024

// INDIANPHARMAPOST

PhytoSquene® Assessed: Your plant-powered vaccine adjuvant

29 Jul 2024

// FIERCE PHARMA

DATA COMPILATION
#PharmaFlow

Contact Supplier

Website

BioPharm America

Attending

Book a meeting

envelop Contact Supplier

DIGITAL CONTENT

43 CORPORATE CONTENT #SupplierSpotlight, 1 DATA COMPILATION #PharmaFlow, 235 NEWS #PharmaBuzz

media
43 CORPORATE CONTENT #SupplierSpotlight
1 DATA COMPILATION #PharmaFlow
235 NEWS #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

40 All APIs, 14 USDMF, 22 CEP/COS, 27 JDMF, 7 KDMF, 22 NDC API, 2 VMF, 4 Listed APIs

40 All APIs
14 USDMF
22 CEP/COS
27 JDMF
7 KDMF
22 NDC API
2 VMF
4 Listed APIs

DEVELOPMENTS

7 Drugs in Development

7 Drugs in Development

SERVICES

API Manufacturing, Drug Product Manufacturing, API & Drug Product Development

KEY SERVICES

Oral Technologies, CMO for Controlled Substances, Microbial Fermentation, API Contract Manufacturing, Development of High Potency APIs (HPAPIs), Chiral Synthesis, Drug Delivery Technology, Hot Melt Extrusion, Coating Technology

Oral Technologies
CMO for Controlled Substances
Microbial Fermentation
API Contract Manufacturing
Development of High Potency APIs (HPAPIs)
Chiral Synthesis
Drug Delivery Technology
Hot Melt Extrusion
Coating Technology

EXCIPIENTS

27 All Excipients, 22 Listed Products, 27 USDMF, 1 NDC API, 2 VMF

excipientPortfolio
27 All Excipients
22 Listed Products
27 USDMF
1 NDC API
2 VMF

EXCIPIENTS BY INGREDIENTS

PLASACRYL T20, L Lysine HCl Excipient, Glycine Excipient, L-Aspartic Acid, Ammonia Methacrylate Copolymer Type A, L-Valine Excipient, L Serine Excipient, L-Proline, DL-Glutamic Acid, Ammonio Methacrylate Copolymer Type B, L-Lysine Acetate, L Threonine Excipient, Methacrylic Acid Copolymer Type B, METHACRYLIC ACID COPOLYMER TYPE A , L-Phenylalanine, L Tryptophan Excipient, Methacrylic Acid - Ethyl Acrylate Copolymer, PLASACRYL HTP20, L-Leucine, DL-Methionine Excipient, L-Alanine, Amino Methacrylate Copolymer

EXCIPIENTS BY APPLICATIONS

Topical, Controlled & Modified Release, Solubilizers, Film Formers & Plasticizers, Lubricants & Glidants, Disintegrants & Superdisintegrants, Taste Masking, Thickeners and Stabilizers, Coating Systems & Additives

excipientsByApplications
Topical
Controlled & Modified Release
Solubilizers
Film Formers & Plasticizers
Lubricants & Glidants
Disintegrants & Superdisintegrants
Taste Masking
Thickeners and Stabilizers
Coating Systems & Additives

INSPECTIONS & REGISTRATIONS

49 FDA, 28 EDQM, 2 GDUFA

inspections
49 FDA
28 EDQM
2 GDUFA

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

About

Evonik is one of the world leaders in specialty chemicals.
The company is active in >100 countries around the world & generated sales of €15.3 billion & an operating profit (adjusted EBITDA) of €1.66 billion in 2023. Evonik is one of the world’s largest CDMOs with capabilities to manufacture customized APIs & HPAPIs. To address the specific needs of large or complex projects, they have established a broad portfolio of differentiating technologies. These technologies include catalytic & biocatalytic reactions, large-scale cryogenic chemistry, continuous processing, fermentation, PEGs & mPEGs, catalysts, & polymer APIs.